The CPT® Editorial Panel has approved the early release of the most recently approved Molecular Pathology Tier 2 codes. All published changes provided as an early release of these codes are not intended to take effect until the dates below:
Panel Meeting Approval: February
Release Date: March 1
Effective Date: April 1
Panel Meeting Approval: May
Release Date: Sept. 1
Effective Date: Oct. 1
Panel Meeting Approval: September
Release Date: Dec. 1
Effective Date: Jan. 1
As for all other CPT codes, inclusion of a descriptor and its associated code number does not represent endorsement by the AMA of any particular diagnostic or therapeutic procedure or service. Inclusion or exclusion of a procedure or service does not imply any health insurance coverage or reimbursement policy.
It is important to note that further CPT Editorial Panel or Executive Committee actions may affect these codes and/or descriptors. For this reason, code numbers and/or descriptor language in the CPT code set may differ at the time of publication. In addition, further Panel actions may result in gaps in code number sequencing.